文献速递生殖医学

持续的可溶性腺苷酸环化酶(sAC)生成的cAMP是人类精子超激活运动所必需且充分的

Sustained soluble adenylyl cyclase (sAC)-generated cAMP is necessary and sufficient for hyperactivated motility in human sperm.
PubMed 文献 · Hum Reprod · 2026-01-01

本研究通过计算机辅助精子分析系统和cAMP ELISA,检测健康供精者精子在获能培养基成分(HCO3-和白蛋白)作用下cAMP生成与运动的变化动力学。结果显示HCO3-刺激sAC依赖性cAMP产生并在最早测量时间点即转换为超激活运动,维持超激活运动需要持续sAC激活,超激活运动似乎是可逆过程。

要点

  • HCO3-刺激sAC依赖性cAMP产生并在最早测量时间点即转换为超激活运动。
  • 维持超激活运动需要持续sAC激活,超激活运动似乎是可逆过程。
  • 不同解离速率的sAC抑制剂是研究生理背景下sAC激活动力学的有用工具。

核心结论

  • sAC生成的cAMP快速启动并维持人类精子超激活运动。
  • 人类精子超激活发生在获能早期且超激活运动是可逆的。
  • sAC依赖的快速超激活运动可能允许人类精子逃离严苛的阴道环境。
  • sAC调节精子运动的作用使其成为男性和女性避孕的最佳靶点。

研究设计与样本

  • 本研究评估了无已知生育问题的健康精液供者精子在获能培养基成分(HCO3-和白蛋白)作用下的cAMP生成和运动动力学。
  • 对照包括cAMP激动剂和腺苷酸环化酶抑制剂。
  • 通过计算机辅助精子分析(CASA)系统分析供者精液样本纯化后精子的运动,并使用cAMP ELISA定量细胞内cAMP。

主要发现

  • HCO3-刺激sAC依赖性cAMP产生并在最早测量时间点即转换为超激活运动。
  • 精子超激活运动似乎是可逆过程,因为维持超激活运动需要持续sAC激活。
  • 不同解离速率的sAC抑制剂被证明是研究生理背景下sAC激活动力学的有用工具。

临床怎么用

  • 作者认为这些发现提出了一种可能性:sAC依赖的快速超激活运动允许人类精子逃离严苛的阴道环境。
  • 作者指出sAC调节精子运动的作用使其成为男性和女性避孕的最佳靶点。
  • 作者指出不同解离速率的sAC抑制剂是研究生理背景下sAC激活动力学的有用工具。

局限性

  • 用于测量超激活运动的CASA系统采用快照技术,精子轨迹仅观察短时间段。
  • 这是一项在 aqueous 溶液中对精子运动参数的离体研究。
  • 所用条件是为成功IVF建立的,本研究的获能诱导超激活运动已被证明对IVF至关重要并与体内受精能力正相关。
  • 然而在体内,射出的精子必须穿过由黏稠黏液衬里的女性生殖道才能到达受精部位。
  • 未来研究应检查黏度更准确反映女性生殖道黏液衬里环境的溶液中的运动行为。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: How does soluble adenylyl cyclase (sAC)-generated cyclic AMP (cAMP) control hyperactivated motility in human sperm? SUMMARY ANSWER: sAC-generated cAMP rapidly initiates and is required to maintain hyperactivated motility in human sperm. WHAT IS KNOWN ALREADY: Mouse and human sperm devoid of sAC activity (either genetically or pharmacologically) are immotile and do not undergo capacitation; thus, the HCO3--dependent stimulation of sAC and consequent increase in cAMP is responsible for activating basal motility and initiating capacitation in multiple mammalian species. Among the changes sperm undergo during capacitation is acquisition of hyperactivated motility, which is presumed to be essential for male fertility. STUDY DESIGN, SIZE, DURATION: In this study, the kinetics of cAMP generation and motility were assessed in sperm from healthy semen donors with no known fertility issues subjected to capacitating media components (HCO3- and albumin). Controls included cAMP agonists and adenylyl cyclase inhibitors. PARTICIPANTS/MATERIALS, SETTING, METHODS: The motility of sperm purified from donors' semen samples was analyzed by a Computer-Assisted Sperm Analysis (CASA) system, and the intracellular cAMP was quantified using a cAMP ELISA. MAIN RESULTS AND THE ROLE OF CHANCE: HCO3- stimulates sAC-dependent cAMP production and the transition to hyperactivated motility at the earliest times measured. Sperm hyperactivated motility seems to be a reversible process, as maintaining hyperactivated motility requires sustained sAC activation. LIMITATIONS, REASONS FOR CAUTION: The CASA system, used to measure hyperactivated motility, employs snapshot technology; sperm trajectories are observed for only short segments of time. This is an ex vivo study of sperm motility parameters in aqueous solutions. The conditions used were established for successful IVF, and the capacitation-induced hyperactivated motility studied here is proven essential for IVF and positively correlated with in vivo fertilization competence. However, in vivo, ejaculated sperm must navigate through the female reproductive tract, which is lined by viscous mucus, to reach the site of fertilization. Future studies should examine motility behaviors in solutions whose viscosity more accurately reflects the mucus-lined environment of the female reproductive tract. WIDER IMPLICATIONS OF THE FINDINGS: There are two novel findings presented here; that hyperactivation of human sperm occurs early during capacitation and that hyperactivated motility is reversible. These findings raise the possibility that the rapid, sAC-dependent hyperactivated motility allows human sperm to escape the harsh vaginal environment. Its roles modulating sperm motility define sAC as an optimal target for both male and female contraception. Additionally, sAC inhibitors with different off-rates are shown here to be useful tools enabling us to study the kinetics of sAC activation in a physiological context. STUDY FUNDING/COMPETING INTEREST(S): The research was funded by Male Contraceptive Initiative (to J.B. and L.R.L.) and National Institutes of Health via HD113015 and HD111549 (to J.B. and L.R.L.). C.R. was awarded a Male Contraceptive Initiative fellowship. L.R.L. and J.B. are co-inventors of a panel of in vivo, validated sAC inhibitors (patent PCT/US2022/02652) and are co-founders, co-owners, and members of the Board of Directors of Sacyl Pharmaceuticals Inc., which licensed the sAC inhibitors for development into on-demand male contraceptives. C.R. has been a paid consultant to Sacyl Pharmaceuticals Inc. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ritagliati C, Devine F, Buck J, et al. Sustained soluble adenylyl cyclase (sAC)-generated cAMP is necessary and sufficient for hyperactivated motility in human sperm. Hum Reprod. 2026. PMID: 41247380. doi:10.1093/humrep/deaf225

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。